Hi there!
We track 49,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

Genesis Molecular AI applies its GEMS platform to design potent, selective small-molecule drug candidates for challenging protein targets. The company combines generative molecular AI (including the…

Genesis Molecular AI applies its GEMS platform to design potent, selective small-molecule drug candidates for challenging protein targets. The company combines generative molecular AI (including the…
Core offering: GEMS generative AI + physics platform for small-molecule drug discovery
Founded: 2019
Headquarters: San Diego, California
Notable partners/integrations: Collaborations with Gilead and Incyte
Recent funding: Series B $200M (Aug 21, 2023)
Small-molecule drug discovery for challenging protein targets in oncology and immunology
2019
Biotechnology
Seed round led by Andreessen Horowitz
52000000
Series A announced Dec 2, 2020
200000000
Series B closed Aug 21, 2023; included Fidelity, BlackRock, NVentures among participants
“Andreessen Horowitz, Rock Springs Capital, Fidelity, BlackRock, NVentures, Menlo Ventures”
Your next opportunity is in here somewhere. Sign up to explore 49,000+ startups and their open roles. No spam. No gamification. Just jobs.
49,000+
Startups
44,000+
Open Roles
0+
New This Week